Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin, Doxorubicin and Cisplatin in Recurrent or Advanced Uterine Sarcomas
NCT00002993Phase 2Terminated
- Sponsor
- GOG Foundation
- Start
- Aug 1997
- Primary completion
- Jan 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitomycin c, doxorubicin, cisplatin in uterine sarcoma, sponsored by GOG Foundation. Started Aug 1997; status: terminated.
02
Drugs
mitomycin cdoxorubicincisplatin
03
Conditions
uterine sarcoma
Beyond the preview
Go deeper on NCT00002993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002993.